siRNA therapy lowers triglycerides in patients with rare problem

.RESEARCH STUDY EMPHASIZE.19 September 2024.

Plozasiran reduced triglyceride levels by 80% and decreased the threat of pancreatitis in clients with chronic chylomicronemia, along with or without a hereditary medical diagnosis.